The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.

Objective Systemic lupus erythematosus (SLE) is associated with increased susceptibility to infections, including herpes ...

Patients aged 75 years or older who are not immunocompromised should receive a protein subunit respiratory syncytial virus (RSV) vaccine, according to new recommendations from the American College of ...

The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or ...

The new GLA-3M-052-LS+OVA vaccine can be delivered as a nasal spray. Three doses protected mice from infection from SARS-CoV-2 and other coronaviruses for three months, and reduced the viral load in ...

Stanford Medicine researchers developed a nasal spray vaccine that protected mice against viruses, bacteria and allergens — a ...

Hepatitis C virus (HCV) infects an estimated 50 million people worldwide, according to the World Health Organization, and remains a leading cause of cirrhosis and liver cancer. While antiviral drugs ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Monash University in ...

Researchers at University California San Diego School of Medicine have found that a natural fungal supplement taken at the ...

Background Gut microbiota dysbiosis is linked to autism spectrum disorder (ASD) in children. However, the role of bacterial ...

New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients with skin of color expands ...